You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 15, April 16, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Stroke
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reducing the Risk of Stroke

Since this article does not have an abstract, we have provided the first 130 words of the full text and any section headings.

To the Editor: Dr Straus and colleagues1 consider ischemic stroke a "coronary equivalent" and thus recommended reducing low-density lipoprotein (LDL) cholesterol levels to less than 100 mg/dL (2.59 mmol/L) in all patients with ischemic stroke. The authors cited the National Cholesterol Education Program (NCEP) guidelines2 as supporting this position. However, the NCEP guidelines define only stroke due to carotid artery disease as a coronary risk equivalent. The NCEP guidelines do not provide recommendations on management of LDL cholesterol in patients with ischemic stroke of other mechanisms, although such treatment may be warranted on the basis of other risk factors and absolute LDL levels. The implications of these positions are quite different.

Furthermore, neither the guidelines of Straus et al nor those of the NCEP are based on actual trial results.

Kamakshi Lakshminarayan, MD, PhD; David C. Anderson, MD
Department of Neurology
Hennepin County Medical Center and University of Minnesota
Minneapolis

1. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA. 2002;288:1388-1395. FREE FULL TEXT
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497. FREE FULL TEXT

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289:1928.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Reducing the Risk of Stroke
Albert Fournier, Roxana Oprisiu, Michel Andrejak, Jean Michel Achard, and Leonardo Fernandez
JAMA. 2003;289(15):1927-1928.
EXTRACT | FULL TEXT  

Reducing the Risk of Stroke
Howard S. Kirshner
JAMA. 2003;289(15):1928.
EXTRACT | FULL TEXT  

Reducing the Risk of Stroke
James M. Gebel and Louis R. Caplan
JAMA. 2003;289(15):1928.
EXTRACT | FULL TEXT  

Reducing the Risk of Stroke—Reply
Sharon E. Straus, Finlay A. McAlister, and Sumit R. Majumdar
JAMA. 2003;289(15):1929.
EXTRACT | FULL TEXT  

New Evidence for Stroke Prevention: Scientific Review
Sharon E. Straus, Sumit R. Majumdar, and Finlay A. McAlister
JAMA. 2002;288(11):1388-1395.
ABSTRACT | FULL TEXT  

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
JAMA. 2001;285(19):2486-2497.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.